Package 62135-969-90

Brand: moexipril hydrochloride

Generic: moexipril hydrochloride
NDC Package

Package Facts

Identity

Package NDC 62135-969-90
Digits Only 6213596990
Product NDC 62135-969
Product ID 62135-969_3001c14d-1545-86fb-e063-6294a90a035f
Description

90 TABLET, FILM COATED in 1 BOTTLE (62135-969-90)

Marketing

Marketing Status
Marketed Since 2025-03-05
Brand moexipril hydrochloride
Generic moexipril hydrochloride
Sample Package No

Linked Drug Pages (1)

Moexipril Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3001c14d-1545-86fb-e063-6294a90a035f", "openfda": {"upc": ["0362135967901", "0362135969905"], "unii": ["Q1UMG3UH45"], "rxcui": ["1299896", "1299897"], "spl_set_id": ["5c24072c-9769-4cb5-b8da-bf814d21391d"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (62135-969-90)", "package_ndc": "62135-969-90", "marketing_start_date": "20250305"}], "brand_name": "Moexipril Hydrochloride", "product_id": "62135-969_3001c14d-1545-86fb-e063-6294a90a035f", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]"], "product_ndc": "62135-969", "generic_name": "Moexipril Hydrochloride", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Moexipril Hydrochloride", "active_ingredients": [{"name": "MOEXIPRIL HYDROCHLORIDE", "strength": "15 mg/1"}], "application_number": "ANDA077536", "marketing_category": "ANDA", "marketing_start_date": "20061130", "listing_expiration_date": "20261231"}